Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

September 2018

Column

Clinical Pathways GPS
09/13/2018
Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD—Column Editor
As the Blue Ribbon report of the Cancer Moonshot1 called for in 2016, we need to build the national cancer data ecosystem that is equal in dimension to the disease burden cancer imposes on society and the resources...
As the Blue Ribbon report of the Cancer Moonshot1 called for in 2016, we need to build the national cancer data ecosystem that is equal in dimension to the disease burden cancer imposes on society and the resources...
As the...
09/13/2018
Journal of Clinical Pathways
Editor's Page
09/13/2018
Winston Wong, PharmD, Editor-in-Chief
The advancements made in health care, and oncology care specifically, have improved treatment and patient care tremendously, and have the potential to make an even greater impact as care delivery becomes more...
The advancements made in health care, and oncology care specifically, have improved treatment and patient care tremendously, and have the potential to make an even greater impact as care delivery becomes more...
The...
09/13/2018
Journal of Clinical Pathways
Business of Pathways
09/13/2018
Ira Klein, MD, MBA, FACP—Column Editor
The current system of health care delivery and payment has tremendous inefficiencies that relate to an inability to share data among multiple parties, and from that sharing, glean useful and actionable information...
The current system of health care delivery and payment has tremendous inefficiencies that relate to an inability to share data among multiple parties, and from that sharing, glean useful and actionable information...
The...
09/13/2018
Journal of Clinical Pathways
Pharma Insights
09/13/2018
Dominic Galante, MD, MS
Larry Blandford, PharmD—Column Editor
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the health care delivery system continues its transition to a value-based reimbursement model, pharmacies face many of the same market pressures as other health care providers to improve patient outcomes and...
As the...
09/13/2018
Journal of Clinical Pathways
Viewpoint
09/13/2018
A Mark Fendrick, MD
Margaret Shope, BS
Successful implementation of precision medicine will need to address several system-wide challenges, including administrative complexities, the creation of new financing models, and aligning provider- and...
Successful implementation of precision medicine will need to address several system-wide challenges, including administrative complexities, the creation of new financing models, and aligning provider- and...
...
09/13/2018
Journal of Clinical Pathways
Counterpoint
09/13/2018
Jason Shafrin, PhD
Precision benefit design is an extension of the concept of value-based insurance design (VBID), which aims to link patient benefit design and coinsurance to the likely benefit of a treatment net of its cost. Whereas...
Precision benefit design is an extension of the concept of value-based insurance design (VBID), which aims to link patient benefit design and coinsurance to the likely benefit of a treatment net of its cost. Whereas...
...
09/13/2018
Journal of Clinical Pathways

Department

Research in Review
09/13/2018
JCP Editors
Large-Scale Sequencing Identifies Predisposition Genes Associated With Gynecologic Cancers A recent study published in JAMA Oncology identified several non-BRCA predisposition genes associated with ovarian and...
Large-Scale Sequencing Identifies Predisposition Genes Associated With Gynecologic Cancers A recent study published in JAMA Oncology identified several non-BRCA predisposition genes associated with ovarian and...
...
09/13/2018
Journal of Clinical Pathways
Conference Preview
09/13/2018
JCP Editors
Increased spending on cancer care can be attributed to a number of contributing factors, including an aging population, earlier diagnoses, and longer survival rates. Medical advancements in surgeries, radiation...
Increased spending on cancer care can be attributed to a number of contributing factors, including an aging population, earlier diagnoses, and longer survival rates. Medical advancements in surgeries, radiation...
...
09/13/2018
Journal of Clinical Pathways

Insights

Interview
09/13/2018
JCP Editors
The 2018 National Comprehensive Cancer Network (NCCN) Annual Conference was held from March 22-24, in Orlando, FL. After the keynote presentations, a multistakeholder roundtable discussion moderated by Clifford...
The 2018 National Comprehensive Cancer Network (NCCN) Annual Conference was held from March 22-24, in Orlando, FL. After the keynote presentations, a multistakeholder roundtable discussion moderated by Clifford...
The...
09/13/2018
Journal of Clinical Pathways

Feature

Perspectives
09/13/2018
Guy Wood-Gush, MBBS, MBA
Vivek Patkar, MBBS, MRCS, FEBS
Abstract: Due to technologic and societal shifts, it seems clear that patients will be much more involved in their care going forward. Health care providers and decision-makers should consider these shifting...
Abstract: Due to technologic and societal shifts, it seems clear that patients will be much more involved in their care going forward. Health care providers and decision-makers should consider these shifting...
...
09/13/2018
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement